Immunoprevention of KRAS-driven lung adenocarcinoma by a multipeptide vaccine

Lung cancer remains the leading cause of cancer death worldwide. Mutations in KRAS are detected in up to 30% of lung cancer cases. No effective therapies specifically targeting mutant KRAS have been developed. Vaccination against KRAS mutants is one of the venues of active exploration. The present s...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Jing, Zhang, Qi, Sei, Shizuko, Shoemaker, Robert H., Lubet, Ronald A., Wang, Yian, You, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5669920/
https://www.ncbi.nlm.nih.gov/pubmed/29137294
http://dx.doi.org/10.18632/oncotarget.19831

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5669920/
https://www.ncbi.nlm.nih.gov/pubmed/29137294
http://dx.doi.org/10.18632/oncotarget.19831

Ejemplares similares